Profile of SARS-CoV-2

The recent emergence of a new coronavirus (severe acute respiratory syndrome coronavirus‑2, SARS-CoV-2) that is transmitted efficiently among humans and can result in serious disease and/or death has become a global threat to public health and economy. In this article, we describe some of the most i...

Descripción completa

Detalles Bibliográficos
Autores principales: Heinz, Franz X., Stiasny, Karin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Vienna 2020
Materias:
Main Topic
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7597426/
https://www.ncbi.nlm.nih.gov/pubmed/33125580
http://dx.doi.org/10.1007/s00508-020-01763-1
_version_ 1783602345335062528
author Heinz, Franz X.
Stiasny, Karin
author_facet Heinz, Franz X.
Stiasny, Karin
author_sort Heinz, Franz X.
collection PubMed
description The recent emergence of a new coronavirus (severe acute respiratory syndrome coronavirus‑2, SARS-CoV-2) that is transmitted efficiently among humans and can result in serious disease and/or death has become a global threat to public health and economy. In this article, we describe some of the most important characteristics of this new virus (including gaps in our understanding) and provide a perspective of ongoing activities for developing virus-specific countermeasures, such as vaccines and antiviral drugs.
format Online
Article
Text
id pubmed-7597426
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Springer Vienna
record_format MEDLINE/PubMed
spelling pubmed-75974262020-11-02 Profile of SARS-CoV-2 Heinz, Franz X. Stiasny, Karin Wien Klin Wochenschr Main Topic The recent emergence of a new coronavirus (severe acute respiratory syndrome coronavirus‑2, SARS-CoV-2) that is transmitted efficiently among humans and can result in serious disease and/or death has become a global threat to public health and economy. In this article, we describe some of the most important characteristics of this new virus (including gaps in our understanding) and provide a perspective of ongoing activities for developing virus-specific countermeasures, such as vaccines and antiviral drugs. Springer Vienna 2020-10-30 2020 /pmc/articles/PMC7597426/ /pubmed/33125580 http://dx.doi.org/10.1007/s00508-020-01763-1 Text en © The Author(s) 2020 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
spellingShingle Main Topic
Heinz, Franz X.
Stiasny, Karin
Profile of SARS-CoV-2
title Profile of SARS-CoV-2
title_full Profile of SARS-CoV-2
title_fullStr Profile of SARS-CoV-2
title_full_unstemmed Profile of SARS-CoV-2
title_short Profile of SARS-CoV-2
title_sort profile of sars-cov-2
topic Main Topic
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7597426/
https://www.ncbi.nlm.nih.gov/pubmed/33125580
http://dx.doi.org/10.1007/s00508-020-01763-1
work_keys_str_mv AT heinzfranzx profileofsarscov2
AT stiasnykarin profileofsarscov2

Ejemplares similares